SCHEMBL14725660

SCHEMBL14725660

c1ccc(-n2c3ccccc3c3cccc(-c4cc5cc6c(cc(-c7cccc8c9ccccc9n(-c9ccccc9)c78)c7ccc8c9ccccc9sc8c76)cc5c5c4ccc4c6ccccc6sc45)c32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ ALOX5 P09917 1/20 0.35
▸ PRKDC P78527 5/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ DUSP3 P51452 1/20 0.33
▸ MAPT P10636 3/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ PDE1B Q01064 1/20 0.32
▸ PDE3A Q14432 1/20 0.32
▸ PDE11A Q9HCR9 1/20 0.32
▸ PARP14 Q460N5 1/20 0.31
▸ TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14725762 0.91 L3MBTL1 (0.37) ATMKDM4EL3MBTL1ALOX5PRKDC
SCHEMBL20706875 0.84 ATM (0.46) ATMKDM4EL3MBTL1ALOX5PRKDC
SCHEMBL14725657 0.82 ATM (0.40) ATMKDM4EL3MBTL1ALOX5PRKDC
SCHEMBL14725761 0.81 L3MBTL1 (0.38) ATMKDM4EL3MBTL1ALOX5DUSP3
SCHEMBL17299396 0.81 ATM (0.45) ATMKDM4EL3MBTL1MAPTRXFP1
SCHEMBL20175512 0.81 ATM (0.40) ATMKDM4EL3MBTL1ALOX5PRKDC
SCHEMBL14296061 0.80 KDM4E (0.41) ATMKDM4EL3MBTL1ALOX5PRKDC
SCHEMBL14296059 0.80 ALOX5 (0.47) ATMKDM4EL3MBTL1ALOX5PRKDC
SCHEMBL26312172 0.80 ATM (0.41) ATMKDM4EL3MBTL1ALOX5PRKDC
SCHEMBL17246447 0.80 ALOX5 (0.41) ATMKDM4EL3MBTL1ALOX5PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255084-B2 Heterocyclic compound and organic light-emitting device containing the same SAMSUNG DISPLAY CO., LTD. (KR) 2016-02-09 — — US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 — — US disclosed
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2013-02-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048955-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME TRPC1, TRPC4, TRPC6 ATM 4059/4885KDM4E 1981/4885L3MBTL1 1029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback